
Enseval provides integrated solutions to enhance efficiency, reliability, and growth. From distribution and logistics to healthcare and marketing, we help drive your business forward.
The meeting reflects the Company's commitment to implementing Good Corporate Governance (GCG) while supporting sustainable business operations that remain adaptive to evolving regulatory requirements.
The Company hereby reports that in the first quarter of 2026, the Company recorded Net Sales of IDR 9,057.13 billion, representing an increase of 9.02% compared to Net Sales in the first quarter of 2025 of IDR 8,307.89 billion.
Start and elevate your career journey with Enseval, Indonesia’s largest pharmaceutical and healthcare product distribution and logistics company.
See Vacancy